Bayforest Capital’s Hinge Health HNGE Stock Holding History

Bayforest Capital’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-5,364	Closed	-$445K	–	1252
2026 Q2	$445K	Buy	5,364 +1,017	+23%	+$55.2K	0.41%	9
2026 Q1	$168K	Buy	+4,347	New	+$181K	0.19%	174

Other funds holding HNGE

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Wallace Foundation New York $314M AUM 31.4% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

11.2 Capital Management Las Vegas, Nevada $229M AUM 98.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Bayforest Capital's HNGE Position: Q3 2026 in Review

Bayforest Capital sold out of Hinge Health (HNGE) in Q3 2026, closing a stake of 5,364 shares — an estimated $445K sold.

Bayforest Capital first reported a position in HNGE in Q1 2026 and held it in 2 quarters. The position peaked at $445K in Q2 2026. 266 funds tracked by Wall St. Rank hold HNGE as of Q3 2026.

Bayforest Capital reported no remaining Hinge Health position as of Q3 2026 after selling out during the quarter.
Bayforest Capital sold 5,364 Hinge Health shares in Q3 2026, an estimated $445K.
Bayforest Capital first reported a position in Hinge Health in Q1 2026 and held it in 2 quarters.
Bayforest Capital's Hinge Health position peaked at $445K in Q2 2026.
266 funds tracked by Wall St. Rank held Hinge Health as of Q3 2026.

Based on Bayforest Capital's 13F filing for Q3 2026, filed 3 Nov 2026.